Cell Genesys, Inc. has been issued a new United States Patent (No. 6,037,177) covering methods of production of its proprietary adeno- associated viral (AAV) gene delivery technology.The patent claims encompass technology for the large-scale production of AAV vectors for both clinical trials and potential product commercialisation. Cell Genesys‘ AAV patent portfolio now includes more than Read more about Cell Genesys Issued Additional Patent For AAV Gene Therapy Technology[…]